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a rare indication for palliative resection
Daniel J Weber1*, John J Coleman2 and Kenneth A Kesler3Abstract
We report a case of a 57-year-old male who presented with an inoperable chest wall sarcoma due to numerous
pulmonary metastases and was treated with chemotherapy and radiation therapy. The patient subsequently
developed refractory bleeding from the chest wall tumor requiring palliative chest wall resection and
reconstruction. The patient made an uneventful recovery however died from metastatic disease 8 months later.
This case represents a very rare indication for palliative chest wall resection.
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Soft tissue sarcomas represent less than 1% of malignan-
cies occurring in the adult population and those arising
from the chest wall comprise between 10% and 20% of
these cases [1,2]. Management of chest wall sarcomas typ-
ically involves a multimodality approach including wide
surgical resection with reconstruction [3]. In most cases,
treatment is intended for curative purposes however occa-
sionally palliative resection in the face of metastatic dis-
ease is needed. Local complications as a result of radiation
therapy can occasionally occur such as skin ulceration,
pain syndromes, and extensive tumor necrosis for which
palliative surgery can improve the remaining quality of life
[4]. We report a case of refractory bleeding from tumor
necrosis after chemotherapy and radiation therapy that re-
quired operative intervention for palliation.
Case presentation
A 57-year-old Caucasian male with a 60-pack-year smok-
ing history and no other co-morbidities or medical condi-
tions initially presented to an outside hospital with a large
left-sided chest wall neoplasm. (Figure 1A) Biopsy revealed
a high-grade pleomorphic sarcoma. At the time of presen-
tation, there were numerous pulmonary metastases and
therefore he was not felt to be a surgical candidate. He re-
ceived 3 cycles of doxorubicin and ifosfamide chemother-
apy resulting in a modest radiographic response in the* Correspondence: dajweber@iupui.edu
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reproduction in any medium, provided the orpulmonary metastases. There was no appreciable change
in the primary neoplasm and he subsequently received ra-
diation therapy to the chest wall with a total of 5,000 cGy
over 25 treatments. Six weeks after receiving radiation, he
developed significant skin and tumor ulceration resulting
in diffuse bleeding refractory to multiple local hemostatic
measures including cauterization and application of nu-
merous topical agents. He required constant blood trans-
fusions, a total of 8 units over a 12-week interval.
Hematologic studies revealed no evidence of an under-
lying bleeding disorder. Attempts at percutaneous tran-
sarterial coil embolization of several chest wall arteries
were subsequently performed however they were unsuc-
cessful and the bleeding and skin ulceration worsened.
(Figure 1B) As the patient’s metastatic disease was felt to
be controlled, he was referred to our institution for urgent
chest wall resection.
At the time of surgery, wide chest wall excision was
performed with an approximately 3 cm circumferential
gross tumor free margin. Ultimately, ribs 4 through 8 were
excised anteriorly from the costal cartilages to the anterior
axillary line posteriorly. The resultant chest wall defect
measured approximately 15 cm by 20 cm (Figure 2B).
Chest wall reconstruction was accomplished with a double
layer of prolene mesh covered by transverse rectus
abdominus myocutaneous (TRAM) flap (Figure 2C). Pat-
hologic analysis demonstrated an undifferentiated high-
grade pleomorphic sarcoma with microscopic tumor free
margins. The patient’s post-operative course was uncom-
plicated and he was discharged after eight days inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Pretreatment chest CT scan (A) showing left chest wall sarcoma and preoperative chest x-ray (B) with evidence of tumor and
multiple embolization coils (dark arrows).
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veloped metastatic disease to the bone and brain and died
8 months following surgery.
Discussion
While surgical resection remains the standard of care for
primary chest wall sarcomas, the role of a multimodality
therapy approach appears promising. There is growing evi-
dence to suggest chemotherapy may reduce systemic recur-
rence and improve survival [5]. Pulmonary metastatectomy
can also be considered for curative purposes in select cases.
For inoperable patients with chest wall sarcomas, a com-
bination of chemotherapy and local radiation is typically
offered to control distant and local disease. Complications
of radiation therapy may occur and include skin ulcer-
ation, pain syndromes, and primary tumor necrosis with
or without superimposed infections [4]. While such com-Figure 2 Bleeding necrotic chest wall sarcoma (A) with chest wall defplications are usually mild, on occasion, combined chest
wall resection with reconstruction is indicated for palli-
ation of severe complications with the goal of improving
the remaining quality of life [6].
Significant and refractory bleeding from soft tissue sarco-
mas following radiation therapy appears however to be a
rare event. A review of the literature (a PubMed search
from 1990 to 2012 with index words: chest wall sarcoma,
resection, bleeding) failed to identify any reports of chest
wall resections performed for refractory bleeding. The de-
cision to pursue palliative resection is certainly challenging
for both patients and caregivers. When multiple efforts in-
cluding arterial embolization failed to stop hemorrhage in
our patient, chest wall resection and reconstruction clearly
became necessary. Although the optimal timing of surgery
is unknown in these situations, we speculate that earlier re-
ferral for resection could have been considered in this case.ect before (B) and after reconstruction (C).
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In summary, we encountered a rare case of significant and
refractory bleeding from a chest wall sarcoma following
radiation therapy. The high-grade and large size of the pri-
mary neoplasm may have contributed to this unusual
complication. Bleeding refractory to conservative mea-
sures, along with other significant complications typically
following radiation therapy, can be indications for pallia-
tive chest wall resection and reconstruction. Although
seemingly radical in the face of incurable disease, surgery
can allow an extended or improved quality of life.
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